Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 30;9(1):52.
doi: 10.1038/s41421-023-00542-2.

TGF-β controls development of TCRγδ+CD8αα+ intestinal intraepithelial lymphocytes

Affiliations

TGF-β controls development of TCRγδ+CD8αα+ intestinal intraepithelial lymphocytes

Jiajia Han et al. Cell Discov. .

Abstract

γδ intestinal intraepithelial lymphocytes (IELs) constitute the majority of IELs with unique CD8αα+ homodimers that are distinct from γδT cells in other tissues. However, it remains largely unclear how those cells develop. Here we show that transforming growth factor beta (TGF-β) signaling controls the development of TCRγδ+CD8αα+ IELs. Deletion of TGF-β receptors or Smad3 and Smad2 in bone marrow stem cells caused a deficiency of TCRγδ+CD8αα+ IELs in mixed bone marrow chimeric mice. Mechanistically, TGF-β is required for the development of TCRγδ+CD8αα+ IELs thymic precursors (CD44-CD25- γδ thymocytes). In addition, TGF-β signaling induced CD8α in thymic γδT cells and maintained CD8α expression and survival in TCRγδ+CD8αα+ IELs. Moreover, TGF-β also indirectly controls TCRγδ+CD8αα+ IELs by modulating the function of intestinal epithelial cells (IECs). Importantly, TGF-β signaling in TCRγδ+CD8αα+ IELs safeguarded the integrity of the intestinal barrier in dextran sulfate sodium (DSS)-induced colitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Fewer TCRγδ+CD8αα+ IELs in TGF-β signaling-deficient mice.
a Representative FACS plot of IEL staining from 4–5-week-old CD45.1 + R1 WT and CD45.1 + R1 KO mixed BM chimeric mice. BM cells were from R1 KO (5 days tamoxifen-treated Tgfbr1f/f Esr1-cre) and R1 WT mice (5 days tamoxifen-treated Tgfbr1+/+ Esr1-cre or oil-treated Tgfbr1f/f Esr1-cre) mixed with BM cells from CD45.1 mice. b, c Frequency (b) and absolute number (c) of TCRγδ+CD8αα+ IELs. d, e Frequency (d) and absolute number (e) of TCRγδ+CD8αβ IELs. f, g Frequency (f) and absolute number (g) of TCRγδ+CD8αα+ IELs from R2 KO (5 days tamoxifen-treated Tgfbr2f/f Esr1-cre) and R2 WT (tamoxifen-treated Tgfbr2+/+ Esr1-cre or oil-treated Tgfbr2f/f Esr1-cre) BM chimeric mice. h, i Frequency (h) and absolute number (i) of TCRγδ+CD8αα+ IELs from 5-day-tamoxifen-treated Tgfbr1f/f TCRδ ER Cre mice and age-matched Tgfbr1+/+ TCRδ ER Cre control littermates.*P < 0.05; **P < 0.01; ***P < 0.001; and ****P < 0.0001; ns no significant difference (unpaired two-tailed Student’s t-test or ANOVA). Data were representative of at least four independent experiments (means ± SEM).
Fig. 2
Fig. 2. TGF-β controls TCRγδ+CD8αα+ IELs development in a Smad2/3-dependent way.
a Representative FACS plot of γδ IELs with CD8α and CD8β staining in Smad3−/− and age-matched control littermates (Smad3+/+). b, c Frequency (b) and absolute number (c) of TCRγδ+CD8αα+ IELs. d Representative FACS plot of γδ IELs with CD8α and CD8β staining from mice transferred with BM cells from Smad2/3dko mice (Smad2 and Smad3 double KO, with 5 days of tamoxifen treatment) or Smad2/3+/+ littermates (with 5 days of tamoxifen treatment). e, f Frequency (e) and absolute number (f) of TCRγδ+CD8αα+ IELs from mice in d. *P < 0.05 and **P < 0.01 (unpaired two-tailed Student’s t-test). Data were representative of at least three independent experiments (means ± SEM).
Fig. 3
Fig. 3. Fewer thymic γδ IEL precursors in TGF-β receptor I-deficient mice.
a MFI of thymic γδT cells in the same CD45.1 + R1 WT and CD45.1 + R1 KO BM chimeric model as in Fig. 1a–e. b Representative FACS plot of thymic γδT cells with CD44 and CD25 staining. c, d Statistical results of frequency (c) and absolute number (d) of CD44CD25 population in b. e, f Frequency (e) and absolute number (f) of CD44CD25+ population. g, h Frequency (g) and absolute number (h) of CD44+CD25+ population. i, j Frequency (i) and absolute number (j) of CD44+CD25 population. *P < 0.05; **P < 0.01; ***P < 0.001; and ****P < 0.0001; ns no significant difference (unpaired two-tailed Student’s t-test or ANOVA). Data were representative of at least three independent experiments (means ± SEM).
Fig. 4
Fig. 4. TGF-β regulates CD103 expression in thymic γδT cells and γδ IELs.
a Representative histogram of CCR9 on thymic γδT cells from the same CD45.1 + R1 WT and CD45.1 + R1 KO BM chimeric mice as in Fig. 1a–e. b, c Frequency (b) and MFI (c) of CCR9 on thymic CD44CD25 γδT cells. d, e Frequency (d) and MFI (e) of CCR9 on TCRγδ+CD8αα+ IELs. f–h Representative histogram (f), frequency (g), and MFI (h) of CD103 on TCRγδ+CD8αα+ IELs. *P < 0.05; **P < 0.01; ***P < 0.001; and ****P < 0.0001; ns no significant difference (ANOVA). Data were representative of at least three independent experiments (means ± SEM).
Fig. 5
Fig. 5. TGF-β induces CD8α, but not CD8β expression in γδT cells.
a, b Relative expression of CD8α (a) and CD8β (b) to Hprt in overnight-cultured thymic γδT cells from C57BL/6 J mice in culture conditions of 1 μg/mL anti-CD3 combined with medium only (Ctrl), or in the presence of 2 ng/mL TGF-β1 (TGF-β) or 5 μM SB431542 (SB, TGF-β inhibitor), and detected by quantitative PCR. c Representative plot of 2-day-cultured thymic γδT cells from C57BL/6 J mice with CD8α staining in the presence of IL-2 (100 U/mL) based on culture condition of a to keep cells survive well in long-term culture. d Frequency of CD8α on thymic γδT cells from the same cells as in c. e, f Relative expression of Runx3 (e) and Zbtb7b (Th-Pok) (f) to Hprt in cells with the same culture condition as in a and detected by quantitative PCR. g, h Relative expression of CD8α (g) and CD8β (h) to Hprt on overnight-cultured splenic γδT cells from C57BL/6 J mice in the same culture condition as in a and detected by quantitative PCR. i, j Relative expression of CD8α to Hprt in overnight-cultured TCRγδ+CD8αα+ IELs (i) or TCRγδ+CD8αβ IELs (j) from C57BL/6 J mice detected by quantitative PCR. *P < 0.05 and ***P < 0.001; ns no significant difference (unpaired two-tailed Student’s t-test). Data were representative of at least three independent experiments (means ± SEM).
Fig. 6
Fig. 6. TGF-β indirectly regulates TCRγδ+CD8αα+ IELs by affecting the function of IECs.
a Representative FACS plot of CD8α and CD8β expression on TCRγδ+CD8αα+ IELs co-cultured with IECs in different settings. b, c Frequency of TCRγδ+CD8αα+ IELs population (b) and Ki67 expression on TCRγδ+CD8αα+ IELs (c). d Representative FACS plot of CD8α and CD8β expression on TCRγδ+CD8αβ IELs. e, f Frequency of TCRγδ+CD8αα+ IELs population after co-culture (e) and Ki67 expression on TCRγδ+CD8αβ IELs (f). g Representative FACS plot of CD8α and CD8β expression on γδ IELs of Smad3+/+ or Smad3−/− recipient mice transferred with BM cells from C56BL/6 J mice for a month. h Frequency of CD8αα+ population of γδ IELs from Smad3+/+ and Smad3−/− recipient mice. i–k Frequency of Vγ7 (i), Vγ1 (j), and Vγ4 (k) subsets of γδ IELs from Smad3+/+ and Smad3−/− recipient mice. *P < 0.05 and **P < 0.01; ns no significant difference (unpaired two-tailed Student’s t-test). Data were representative of three independent experiments (means ± SEM).
Fig. 7
Fig. 7. Lack of TGF-β signaling in γδ IELs exacerbates DSS-induced colitis.
a The volcano plot shows the differential expression profile of genes in TCRγδ+CD8αα+ IELs from R1 WT and R1 KO mice and examined by RNA-seq. The gray dots represent non-differentially expressed genes between the two groups, while the upregulated genes in R1 KO mice are pink dots towards the upper end (with log2 fold change value above 0 on the y-axis), and the downregulated genes in R1 KO mice are pink dots towards the lower end (with log2 fold change value below 0 on the y-axis). b FISH visualizes the location of bacteria around the intestinal epithelia in the small intestine of Smad3−/− mice and age-matched littermate controls (Smad3+/+). c FISH visualizes the location of bacteria in the small intestine from 5-day-tamoxifen-treated Tgfbr1f/f TCRδ ER Cre and age-matched Tgfbr1+/+ TCRδ ER Cre littermates. d, e DAI (d) and loss of body weight (e) of Smad3−/− and Smad3+/+ mice treated with 3% DSS drinking water for 7 days. f, g DAI (f) and loss of body weight (g) of Tgfbr1f/f TCRδ ER Cre and Tgfbr1+/+ TCRδ ER Cre control mice treated with DSS for 7 days. h–j Hematoxylin and eosin (H&E) staining for colon from normal Smad3−/− and 5-day-tamoxifen-treated Tgfbr1+/+f TCRδ ER Cre mice (h), and from 3% DSS-treated Smad3−/− vs Smad3+/+ mice in d and e (i), or 3% DSS-treated Tgfbr1f/f TCRδ ER Cre versus Tgfbr1+/+ TCRδ ER Cre mice in f and g (j). *P < 0.05 (unpaired two-tailed Student’s t-test or DEseq2 statistical test). Data were representative of at least two independent experiments (means ± SEM). RNA-seq samples were collected from three or four independent experiments.

References

    1. Olivares-Villagómez D, Van Kaer L. Intestinal intraepithelial lymphocytes: sentinels of the mucosal barrier. Trends Immunol. 2018;39:264–275. doi: 10.1016/j.it.2017.11.003. - DOI - PMC - PubMed
    1. Cheroutre H, Lambolez F, Mucida D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat. Rev. Immunol. 2011;11:445–456. doi: 10.1038/nri3007. - DOI - PMC - PubMed
    1. Edelblum KL, et al. γδ Intraepithelial lymphocyte migration limits transepithelial pathogen invasion and systemic disease in mice. Gastroenterology. 2015;148:1417–1426. doi: 10.1053/j.gastro.2015.02.053. - DOI - PMC - PubMed
    1. Hoytema van Konijnenburg DP, et al. Intestinal epithelial and intraepithelial T cell crosstalk mediates a dynamic response to infection. Cell. 2017;171:783–794.e713. doi: 10.1016/j.cell.2017.08.046. - DOI - PMC - PubMed
    1. Swamy M, et al. Intestinal intraepithelial lymphocyte activation promotes innate antiviral resistance. Nat. Commun. 2015;6:7090. doi: 10.1038/ncomms8090. - DOI - PMC - PubMed